-
DE
K51.1 – Ulcerative Proctocolitis: ICD-10
K51.1 is the ICD-10 code for ulcerative proctocolitis – a chronic inflammatory bowel disease affecting the rectum and sigmoid colon.
Add as Preferred SourceThings worth knowing about "K51.1"
K51.1 is the ICD-10 code for ulcerative proctocolitis – a chronic inflammatory bowel disease affecting the rectum and sigmoid colon.
What is K51.1?
The ICD-10 code K51.1 refers to ulcerative proctocolitis, a specific subtype of ulcerative colitis (UC). It is a chronic inflammatory bowel disease (IBD) in which inflammation is limited to the rectum and the sigmoid colon (the last section of the large intestine). Unlike more extensive forms of ulcerative colitis, K51.1 affects only the distal (lower) portion of the colon.
Causes
The exact cause of ulcerative proctocolitis is not yet fully understood. It is believed to result from a combination of factors:
- Genetic predisposition: Certain gene variants increase the risk of developing the condition.
- Dysregulated immune response: The immune system mistakenly attacks the lining of the bowel.
- Alterations in the gut microbiome: An imbalance in gut bacteria may promote inflammation.
- Environmental and lifestyle factors: Stress, diet, and certain medications (e.g., non-steroidal anti-inflammatory drugs) may influence disease activity.
Symptoms
Common symptoms of K51.1 include:
- Bloody diarrhea or blood in the stool
- Mucus in the stool
- Lower abdominal pain, particularly in the left lower abdomen
- Frequent urge to defecate (tenesmus), including at night
- Feeling of incomplete bowel emptying
- In more severe cases: fatigue, weight loss, and anemia
The disease typically follows a relapsing-remitting pattern, with periods of active disease (flares) alternating with periods of remission.
Diagnosis
Diagnosis of ulcerative proctocolitis involves several investigations:
- Colonoscopy: The gold standard for visualizing mucosal changes and obtaining tissue samples (biopsies).
- Histological examination: Microscopic analysis of biopsy specimens to confirm the diagnosis.
- Laboratory tests: Measurement of inflammatory markers (e.g., CRP, fecal calprotectin) and a complete blood count.
- Exclusion of other causes: Stool cultures to rule out infectious causes of bowel disease.
Treatment
Treatment of K51.1 depends on disease severity and aims to control inflammation and maintain remission:
Pharmacological Treatment
- 5-Aminosalicylates (5-ASA, mesalazine): First-line therapy for mild to moderate disease; available as suppositories, enemas, or oral tablets.
- Corticosteroids: Used for short-term management of more severe flares.
- Immunomodulators (e.g., azathioprine): For steroid-dependent or frequently relapsing disease.
- Biologics (e.g., TNF-alpha inhibitors): For refractory cases that do not respond to standard therapies.
Non-Pharmacological Measures
- Dietary adjustments to relieve symptoms
- Stress reduction and psychological support
- Regular gastroenterological follow-up
Surgical Treatment
Surgery is rarely required for K51.1, as the disease is confined to the distal colon. In exceptional cases where all medical treatments have failed or complications arise, surgical intervention may be considered.
Prognosis
Ulcerative proctocolitis (K51.1) generally has a more favorable prognosis compared to more extensive forms of ulcerative colitis. Many patients achieve long-term remission with appropriate treatment. However, in some individuals the disease may extend to involve additional parts of the colon, making regular medical monitoring essential.
References
- World Health Organization (WHO): ICD-10 International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Volume 1. Geneva: WHO; 2019. Available at: https://icd.who.int/browse10
- Harbord M et al.: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Journal of Crohn's and Colitis. 2017;11(6):649–670.
- Feuerstein JD, Moss AC, Farraye FA: Ulcerative Colitis. Mayo Clinic Proceedings. 2019;94(7):1357–1373.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Skip product gallery
Subscription available
Floral
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®30 lozenges
Regular price:
22,90 €
Discount
Subscription available
Lactoferrin 60 Capsules
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
60 Capsules
Sale price:
50,00 €
Regular price:
59,90 €
Subscription available
Multivitamin Mineral Complex
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
30 Capsules
Regular price:
29,90 €
Subscription available
Natural Iron
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
30 Capsules
Regular price:
35,90 €